{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:07:24Z","timestamp":1787047644415,"version":"build-2736575974"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41390-023-02549-7","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:02:46Z","timestamp":1678100566000},"page":"434-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Understanding COVID-19 in children: immune determinants and post-infection conditions"],"prefix":"10.1038","volume":"94","author":[{"given":"Gioacchino Andrea","family":"Rotulo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3066-4719","authenticated-orcid":false,"given":"Paolo","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"2549_CR1","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/INF.0000000000002740","volume":"39","author":"K Bai","year":"2020","unstructured":"Bai, K. et al. Clinical analysis of 25 COVID-19 infections in children. Pediatr. Infect. Dis. J. 39, e100\u2013e103 (2020).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2549_CR2","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","volume":"145","author":"Y Dong","year":"2020","unstructured":"Dong, Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 145, e20200702 (2020).","journal-title":"Pediatrics"},{"key":"2549_CR3","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/INF.0000000000002739","volume":"39","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Children hospitalized with severe COVID-19 in Wuhan. Pediatr. Infect. Dis. J. 39, e91\u2013e94 (2020).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2549_CR4","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder, G., Rezza, G. & Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323, 1775\u20131776 (2020).","journal-title":"JAMA"},{"key":"2549_CR5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180, 934\u2013943 (2020).","journal-title":"JAMA Intern. Med."},{"key":"2549_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ajem.2020.11.066","volume":"42","author":"G Brisca","year":"2021","unstructured":"Brisca, G. et al. The impact of COVID-19 lockdown on children with medical complexity in pediatric emergency department. Am. J. Emerg. Med. 42, 225\u2013227 (2021).","journal-title":"Am. J. Emerg. Med."},{"key":"2549_CR7","doi-asserted-by":"publisher","unstructured":"Bellini, T. et al. Characteristics of COVID-19 patients up to 6 months of age admitted to a paediatric emergency department. Acta Paediatr. 111, 272\u2013274. https:\/\/doi.org\/10.1111\/apa.16166 (2022).","DOI":"10.1111\/apa.16166"},{"key":"2549_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13052-021-00980-2","volume":"47","author":"M Cattalini","year":"2021","unstructured":"Cattalini, M. et al. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics. Ital. J. Pediatr. 47, 24 (2021).","journal-title":"Ital. J. Pediatr."},{"key":"2549_CR9","doi-asserted-by":"publisher","unstructured":"Feldstein, L. R. et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 325, 1074\u20131087. https:\/\/doi.org\/10.1001\/jama.2021.2091 (2021).","DOI":"10.1001\/jama.2021.2091"},{"key":"2549_CR10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","volume":"183","author":"CN Gruber","year":"2020","unstructured":"Gruber, C. N. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell 183, 982\u2013995.e14 (2020).","journal-title":"Cell"},{"key":"2549_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker, E. et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324, 259\u2013269 (2020).","journal-title":"JAMA"},{"key":"2549_CR12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio, C. R. et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183, 968\u2013981.e7 (2020).","journal-title":"Cell"},{"key":"2549_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpeds.2020.10.039","volume":"230","author":"GA Rotulo","year":"2021","unstructured":"Rotulo, G. A. et al. Giant urticaria and acral peeling in a child with coronavirus disease 2019. J. Pediatr. 230, 261\u2013263 (2021).","journal-title":"J. Pediatr."},{"key":"2549_CR14","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1111\/jdv.17283","volume":"35","author":"S Signa","year":"2021","unstructured":"Signa, S. et al. Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? J. Eur. Acad. Dermatol. Venereol. 35, e475\u2013e477 (2021).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2549_CR15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2020.05.145","volume":"83","author":"J Kanitakis","year":"2020","unstructured":"Kanitakis, J., Lesort, C., Danset, M. & Jullien, D. Chilblain-like acral lesions during the COVID-19 pandemic (\u2018COVID toes\u2019): histologic, immunofluorescence, and immunohistochemical study of 17 cases. J. Am. Acad. Dermatol. 83, 870\u2013875 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2549_CR16","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1111\/jdv.16779","volume":"34","author":"C Lesort","year":"2020","unstructured":"Lesort, C. et al. COVID-19 and outbreak of chilblains: are they related? J. Eur. Acad. Dermatol. Venereol. 34, e757\u2013e758 (2020).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2549_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet Lond. Engl. 397, 220\u2013232 (2021).","journal-title":"Lancet Lond. Engl."},{"key":"2549_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","volume":"71","author":"CE Barrett","year":"2022","unstructured":"Barrett, C. E. et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years\u2014United States, March 1, 2020\u2013June 28, 2021. MMWR Morb. Mortal. Wkly. Rep. 71, 59\u201365 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2549_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"2549_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"2549_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2020.05.013","volume":"18","author":"NS Sharif-Askari","year":"2020","unstructured":"Sharif-Askari, N. S. et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol. Ther. Methods Clin. Dev. 18, 1\u20136 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2549_CR22","doi-asserted-by":"crossref","first-page":"e4154","DOI":"10.1093\/cid\/ciaa1911","volume":"73","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Distinct disease severity between children and older adults with coronavirus disease 2019 (COVID-19): impacts of ACE2 expression, distribution, and lung progenitor cells. Clin. Infect. Dis. 73, e4154\u2013e4165 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"2549_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/archdischild-2020-320338","volume":"106","author":"P Zimmermann","year":"2021","unstructured":"Zimmermann, P. & Curtis, N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch. Dis. Child. 106, 429\u2013439 (2021).","journal-title":"Arch. Dis. Child."},{"key":"2549_CR24","doi-asserted-by":"crossref","first-page":"e140766","DOI":"10.1172\/JCI140766","volume":"131","author":"BA Schuler","year":"2021","unstructured":"Schuler, B. A. et al. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium. J. Clin. Invest 131, e140766 (2021).","journal-title":"J. Clin. Invest"},{"key":"2549_CR25","doi-asserted-by":"publisher","unstructured":"Silva, M. G. et al. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels. Pediatr. Res. 1\u20135. https:\/\/doi.org\/10.1038\/s41390-022-02163-z (2022).","DOI":"10.1038\/s41390-022-02163-z"},{"key":"2549_CR26","doi-asserted-by":"crossref","first-page":"e148694","DOI":"10.1172\/jci.insight.148694","volume":"6","author":"CA Pierce","year":"2021","unstructured":"Pierce, C. A. et al. Natural mucosal barriers and COVID-19 in children. JCI Insight 6, e148694 (2021).","journal-title":"JCI Insight"},{"key":"2549_CR27","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","volume":"323","author":"S Bunyavanich","year":"2020","unstructured":"Bunyavanich, S., Do, A. & Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323, 2427 (2020).","journal-title":"JAMA"},{"key":"2549_CR28","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jamapediatrics.2020.3651","volume":"174","author":"T Heald-Sargent","year":"2020","unstructured":"Heald-Sargent, T. et al. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19). JAMA Pediatr. 174, 902 (2020).","journal-title":"JAMA Pediatr."},{"key":"2549_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"2549_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00710-4","volume":"7","author":"G B\u00e1lint","year":"2022","unstructured":"B\u00e1lint, G., V\u00f6r\u00f6s-Horv\u00e1th, B. & Sz\u00e9chenyi, A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct. Target. Ther. 7, 1\u20133 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2549_CR31","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","volume":"94","author":"Y Araf","year":"2022","unstructured":"Araf, Y. et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J. Med. Virol. 94, 1825\u20131832 (2022).","journal-title":"J. Med. Virol."},{"key":"2549_CR32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"RB Seth","year":"2005","unstructured":"Seth, R. B., Sun, L., Ea, C.-K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669\u2013682 (2005).","journal-title":"Cell"},{"key":"2549_CR33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cell.2009.06.015","volume":"138","author":"Y-H Chiu","year":"2009","unstructured":"Chiu, Y.-H., Macmillan, J. B. & Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576\u2013591 (2009).","journal-title":"Cell"},{"key":"2549_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mib.2014.05.011","volume":"20","author":"J-S Yoo","year":"2014","unstructured":"Yoo, J.-S., Kato, H. & Fujita, T. Sensing viral invasion by RIG-I like receptors. Curr. Opin. Microbiol. 20, 131\u2013138 (2014).","journal-title":"Curr. Opin. Microbiol."},{"key":"2549_CR35","doi-asserted-by":"publisher","unstructured":"Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 40, 319\u2013324. https:\/\/doi.org\/10.1038\/s41587-021-01037-9 (2022).","DOI":"10.1038\/s41587-021-01037-9"},{"key":"2549_CR36","doi-asserted-by":"crossref","first-page":"eabd5487","DOI":"10.1126\/scitranslmed.abd5487","volume":"12","author":"CA Pierce","year":"2020","unstructured":"Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 12, eabd5487 (2020).","journal-title":"Sci. Transl. Med."},{"key":"2549_CR37","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045.e9 (2020).","journal-title":"Cell"},{"key":"2549_CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"2549_CR39","unstructured":"Bastard, P. et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci. Immunol. 6, eabl4340 (2021)."},{"key":"2549_CR40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","volume":"148","author":"A Lemarquis","year":"2021","unstructured":"Lemarquis, A. et al. Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis. J. Allergy Clin. Immunol. 148, 96\u201398 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2549_CR41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","volume":"147","author":"I Meyts","year":"2021","unstructured":"Meyts, I. et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J. Allergy Clin. Immunol. 147, 520\u2013531 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2549_CR42","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fimmu.2018.00544","volume":"9","author":"JM Rosenberg","year":"2018","unstructured":"Rosenberg, J. M. et al. Neutralizing anti-cytokine autoantibodies against interferon-\u03b1 in immunodysregulation polyendocrinopathy enteropathy X-linked. Front. Immunol. 9, 544 (2018).","journal-title":"Front. Immunol."},{"key":"2549_CR43","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","volume":"125","author":"JE Walter","year":"2015","unstructured":"Walter, J. E. et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J. Clin. Invest 125, 4135\u20134148 (2015).","journal-title":"J. Clin. Invest"},{"key":"2549_CR44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/MOP.0000000000001062","volume":"33","author":"G Bucciol","year":"2021","unstructured":"Bucciol, G., Tangye, S. G. & Meyts, I. Coronavirus disease 2019 in patients with inborn errors of immunity: lessons learned. Curr. Opin. Pediatr. 33, 648\u2013656 (2021).","journal-title":"Curr. Opin. Pediatr."},{"key":"2549_CR45","doi-asserted-by":"crossref","first-page":"e150867","DOI":"10.1172\/JCI150867","volume":"131","author":"C Meisel","year":"2021","unstructured":"Meisel, C. et al. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1. J. Clin. Invest. 131, e150867 (2021).","journal-title":"J. Clin. Invest."},{"key":"2549_CR46","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).","journal-title":"Science"},{"key":"2549_CR47","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","volume":"3","author":"A Meager","year":"2006","unstructured":"Meager, A. et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3, e289 (2006).","journal-title":"PLoS Med."},{"key":"2549_CR48","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","volume":"9","author":"C Milito","year":"2021","unstructured":"Milito, C. et al. Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. J. Allergy Clin. Immunol. Pract. 9, 2904\u20132906.e2 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2549_CR49","doi-asserted-by":"crossref","first-page":"720205","DOI":"10.3389\/fimmu.2021.720205","volume":"12","author":"EMN Ferr\u00e9","year":"2021","unstructured":"Ferr\u00e9, E. M. N. et al. SARS-CoV-2 spike protein-directed monoclonal antibodies may ameliorate COVID-19 complications in APECED patients. Front. Immunol. 12, 720205 (2021).","journal-title":"Front. Immunol."},{"key":"2549_CR50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.xjtc.2021.03.012","volume":"7","author":"J Kakuturu","year":"2021","unstructured":"Kakuturu, J., McCluskey, C., Casey, F. L., Cicek, S. & Hayanga, J. W. A. Extracorporeal membrane oxygenation to treat a 15-year-old patient with severe coronavirus disease 2019 (COVID-19) respiratory failure. JTCVS Tech. 7, 265\u2013266 (2021).","journal-title":"JTCVS Tech."},{"key":"2549_CR51","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).","journal-title":"Science"},{"key":"2549_CR52","doi-asserted-by":"publisher","unstructured":"Zhang, Q., Bastard, P., Cobat, A. & Casanova, J.-L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 603, 587\u2013598. https:\/\/doi.org\/10.1038\/s41586-022-04447-0 (2022).","DOI":"10.1038\/s41586-022-04447-0"},{"key":"2549_CR53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.aaa1578","volume":"348","author":"MJ Ciancanelli","year":"2015","unstructured":"Ciancanelli, M. J. et al. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348, 448\u2013453 (2015).","journal-title":"Science"},{"key":"2549_CR54","doi-asserted-by":"crossref","first-page":"eabl4348","DOI":"10.1126\/sciimmunol.abl4348","volume":"6","author":"T Asano","year":"2021","unstructured":"Asano, T. et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci. Immunol. 6, eabl4348 (2021).","journal-title":"Sci. Immunol."},{"key":"2549_CR55","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41418-020-00633-7","volume":"27","author":"T Matsuyama","year":"2020","unstructured":"Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K. & Mak, T. W. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 27, 3209\u20133225 (2020).","journal-title":"Cell Death Differ."},{"key":"2549_CR56","doi-asserted-by":"publisher","unstructured":"Abolhassani, H. et al. Inherited IFNAR1 deficiency in a child with both critical COVID-19 pneumonia and multisystem inflammatory syndrome. J. Clin. Immunol. 42, 471\u2013483. https:\/\/doi.org\/10.1007\/s10875-022-01215-7 (2022).","DOI":"10.1007\/s10875-022-01215-7"},{"key":"2549_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10875-021-01166-5","volume":"42","author":"S Khanmohammadi","year":"2022","unstructured":"Khanmohammadi, S., Rezaei, N., Khazaei, M. & Shirkani, A. A case of autosomal recessive interferon alpha\/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19. J. Clin. Immunol. 42, 19\u201324 (2022).","journal-title":"J. Clin. Immunol."},{"key":"2549_CR58","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MOP.0000000000001061","volume":"33","author":"GS Schulert","year":"2021","unstructured":"Schulert, G. S., Blum, S. A. & Cron, R. Q. Host genetics of pediatric SARS-CoV-2 COVID-19 and multisystem inflammatory syndrome in children. Curr. Opin. Pediatr. 33, 549\u2013555 (2021).","journal-title":"Curr. Opin. Pediatr."},{"key":"2549_CR59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2549_CR60","doi-asserted-by":"crossref","first-page":"662989","DOI":"10.3389\/fimmu.2021.662989","volume":"12","author":"L Sui","year":"2021","unstructured":"Sui, L. et al. SARS-CoV-2 membrane protein inhibits type i interferon production through ubiquitin-mediated degradation of TBK1. Front. Immunol. 12, 662989 (2021).","journal-title":"Front. Immunol."},{"key":"2549_CR61","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-00571-x","volume":"18","author":"Y-Z Fu","year":"2021","unstructured":"Fu, Y.-Z. et al. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell. Mol. Immunol. 18, 613\u2013620 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"2549_CR62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41392-020-00438-7","volume":"5","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I\/MDA-5 signaling. Signal Transduct. Target. Ther. 5, 299 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2549_CR63","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/jir.2020.0214","volume":"40","author":"H Xia","year":"2020","unstructured":"Xia, H. & Shi, P.-Y. Antagonism of type i interferon by severe acute respiratory syndrome coronavirus 2. J. Interferon Cytokine Res. 40, 543\u2013548 (2020).","journal-title":"J. Interferon Cytokine Res."},{"key":"2549_CR64","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/jcp.30615","volume":"237","author":"SS Singh","year":"2022","unstructured":"Singh, S. S. et al. Amphiregulin in cellular physiology, health, and disease: potential use as a biomarker and therapeutic target. J. Cell. Physiol. 237, 1143\u20131156 (2022).","journal-title":"J. Cell. Physiol."},{"key":"2549_CR65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.immuni.2020.02.016","volume":"52","author":"A Diefenbach","year":"2020","unstructured":"Diefenbach, A., Gnafakis, S. & Shomrat, O. Innate lymphoid cell-epithelial cell modules sustain intestinal homeostasis. Immunity 52, 452\u2013463 (2020).","journal-title":"Immunity"},{"key":"2549_CR66","doi-asserted-by":"crossref","first-page":"e74681","DOI":"10.7554\/eLife.74681","volume":"11","author":"NJ Silverstein","year":"2022","unstructured":"Silverstein, N. J. et al. Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection. eLife 11, e74681 (2022).","journal-title":"eLife"},{"key":"2549_CR67","doi-asserted-by":"crossref","first-page":"103357","DOI":"10.1016\/j.ebiom.2021.103357","volume":"67","author":"V Seery","year":"2021","unstructured":"Seery, V. et al. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers. EBioMedicine 67, 103357 (2021).","journal-title":"EBioMedicine"},{"key":"2549_CR68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21414-x","volume":"12","author":"MR Neeland","year":"2021","unstructured":"Neeland, M. R. et al. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children. Nat. Commun. 12, 1084 (2021).","journal-title":"Nat. Commun."},{"key":"2549_CR69","doi-asserted-by":"crossref","first-page":"E1383","DOI":"10.3390\/cells9061383","volume":"9","author":"B Tomar","year":"2020","unstructured":"Tomar, B., Anders, H.-J., Desai, J. & Mulay, S. R. Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19. Cells 9, E1383 (2020).","journal-title":"Cells"},{"key":"2549_CR70","doi-asserted-by":"crossref","first-page":"e1009721","DOI":"10.1371\/journal.ppat.1009721","volume":"17","author":"LE Cabrera","year":"2021","unstructured":"Cabrera, L. E. et al. Characterization of low-density granulocytes in COVID-19. PLoS Pathog. 17, e1009721 (2021).","journal-title":"PLoS Pathog."},{"key":"2549_CR71","doi-asserted-by":"crossref","first-page":"e2221616","DOI":"10.1001\/jamanetworkopen.2022.21616","volume":"5","author":"C Di Chiara","year":"2022","unstructured":"Di Chiara, C. et al. Long-term immune response to SARS-CoV-2 infection among children and adults after mild infection. JAMA Netw. Open 5, e2221616 (2022).","journal-title":"JAMA Netw. Open"},{"key":"2549_CR72","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.cell.2021.02.010","volume":"184","author":"EM Anderson","year":"2021","unstructured":"Anderson, E. M. et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell 184, 1858\u20131864.e10 (2021).","journal-title":"Cell"},{"key":"2549_CR73","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","volume":"71","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin. Infect. Dis. 71, 2027\u20132034 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"2549_CR74","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"Q-X Long","year":"2020","unstructured":"Long, Q.-X. et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26, 845\u2013848 (2020).","journal-title":"Nat. Med."},{"key":"2549_CR75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","journal-title":"Nature"},{"key":"2549_CR76","first-page":"e02015","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan, Y. et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J. Virol. 94, e02015\u2013e02019 (2020).","journal-title":"J. Virol."},{"key":"2549_CR77","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","volume":"5","author":"WS Lee","year":"2020","unstructured":"Lee, W. S., Wheatley, A. K., Kent, S. J. & DeKosky, B. J. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat. Microbiol. 5, 1185\u20131191 (2020).","journal-title":"Nat. Microbiol."},{"key":"2549_CR78","doi-asserted-by":"crossref","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","volume":"4","author":"HS Yang","year":"2021","unstructured":"Yang, H. S. et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw. Open 4, e214302 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2549_CR79","doi-asserted-by":"crossref","first-page":"e2021052173","DOI":"10.1542\/peds.2021-052173","volume":"148","author":"F Bonfante","year":"2021","unstructured":"Bonfante, F. et al. Mild SARS-CoV-2 infections and neutralizing antibody titers. Pediatrics 148, e2021052173 (2021).","journal-title":"Pediatrics"},{"key":"2549_CR80","volume":"12","author":"KJ Selva","year":"2021","unstructured":"Selva, K. J. et al. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat. Commun. 12, 2037 (2021).","journal-title":"Nat. Commun."},{"key":"2549_CR81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.037","volume":"227","author":"LM Yonker","year":"2020","unstructured":"Yonker, L. M. et al. Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses. J. Pediatr. 227, 45\u201352.e5 (2020).","journal-title":"J. Pediatr."},{"key":"2549_CR82","doi-asserted-by":"crossref","first-page":"108852","DOI":"10.1016\/j.celrep.2021.108852","volume":"34","author":"N Cotugno","year":"2021","unstructured":"Cotugno, N. et al. Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies. Cell Rep. 34, 108852 (2021).","journal-title":"Cell Rep."},{"key":"2549_CR83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2549_CR84","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.stem.2020.03.014","volume":"26","author":"B de Laval","year":"2020","unstructured":"de Laval, B. et al. C\/EBP\u03b2-dependent epigenetic memory induces trained immunity in hematopoietic stem cells. Cell Stem Cell 26, 793 (2020).","journal-title":"Cell Stem Cell"},{"key":"2549_CR85","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMcibr2011679","volume":"383","author":"A Mantovani","year":"2020","unstructured":"Mantovani, A. & Netea, M. G. Trained innate immunity, epigenetics, and COVID-19. N. Engl. J. Med. 383, 1078\u20131080 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2549_CR86","doi-asserted-by":"crossref","first-page":"837524","DOI":"10.3389\/fimmu.2022.837524","volume":"13","author":"JM Brueggeman","year":"2022","unstructured":"Brueggeman, J. M., Zhao, J., Schank, M., Yao, Z. Q. & Moorman, J. P. Trained immunity: an overview and the impact on COVID-19. Front. Immunol. 13, 837524 (2022).","journal-title":"Front. Immunol."},{"key":"2549_CR87","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","volume":"20","author":"LAJ O\u2019Neill","year":"2020","unstructured":"O\u2019Neill, L. A. J. & Netea, M. G. BCG-induced trained immunity: can it offer protection against COVID-19? Nat. Rev. Immunol. 20, 335\u2013337 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2549_CR88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11095-020-02930-9","volume":"37","author":"R Hajjo","year":"2020","unstructured":"Hajjo, R. & Tropsha, A. A systems biology workflow for drug and vaccine repurposing: identifying small-molecule BCG mimics to reduce or prevent COVID-19 mortality. Pharm. Res. 37, 212 (2020).","journal-title":"Pharm. Res."},{"key":"2549_CR89","unstructured":"Murdoch Childrens Research Institute. BCG Vaccination to Reduce the Impact of COVID-19 in Healthcare Workers (BRACE) Trial; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04327206 (2022)."},{"key":"2549_CR90","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmolb.2020.00120","volume":"7","author":"KR Sidiq","year":"2020","unstructured":"Sidiq, K. R., Sabir, D. K., Ali, S. M. & Kodzius, R. Does early childhood vaccination protect against COVID-19? Front. Mol. Biosci. 7, 120 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"2549_CR91","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e6 (2020).","journal-title":"Cell"},{"key":"2549_CR92","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/pai.13585","volume":"32","author":"N Cotugno","year":"2021","unstructured":"Cotugno, N. et al. Virological and immunological features of SARS\u2010COV\u20102 infected children with distinct symptomatology. Pediatr. Allergy Immunol. 32, 1833\u20131842 (2021).","journal-title":"Pediatr. Allergy Immunol."},{"key":"2549_CR93","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/cbin.11403","volume":"44","author":"N Fathi","year":"2020","unstructured":"Fathi, N. & Rezaei, N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol. Int. 44, 1792\u20131797 (2020).","journal-title":"Cell Biol. Int."},{"key":"2549_CR94","doi-asserted-by":"crossref","first-page":"e28745","DOI":"10.1002\/pbc.28745","volume":"67","author":"C Kosmeri","year":"2020","unstructured":"Kosmeri, C., Koumpis, E., Tsabouri, S., Siomou, E. & Makis, A. Hematological manifestations of SARS-CoV-2 in children. Pediatr. Blood Cancer 67, e28745 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"2549_CR95","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jmv.26208","volume":"93","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review. J. Med. Virol. 93, 234\u2013240 (2021).","journal-title":"J. Med. Virol."},{"key":"2549_CR96","volume":"12","author":"CA Cohen","year":"2021","unstructured":"Cohen, C. A. et al. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat. Commun. 12, 4678 (2021).","journal-title":"Nat. Commun."},{"key":"2549_CR97","doi-asserted-by":"crossref","first-page":"817876","DOI":"10.3389\/fimmu.2022.817876","volume":"13","author":"P Kaaijk","year":"2022","unstructured":"Kaaijk, P. et al. Children and adults with mild COVID-19: dynamics of the memory T Cell response up to 10 months. Front. Immunol. 13, 817876 (2022).","journal-title":"Front. Immunol."},{"key":"2549_CR98","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012.e19 (2020).","journal-title":"Cell"},{"key":"2549_CR99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.it.2020.11.002","volume":"42","author":"P de Candia","year":"2021","unstructured":"de Candia, P., Prattichizzo, F., Garavelli, S. & Matarese, G. T cells: warriors of SARS-CoV-2 infection. Trends Immunol. 42, 18\u201330 (2021).","journal-title":"Trends Immunol."},{"key":"2549_CR100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer, W. T. et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J. Allergy Clin. Immunol. 112, 973\u2013980 (2003).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2549_CR101","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fimmu.2018.00498","volume":"9","author":"ME Rudolph","year":"2018","unstructured":"Rudolph, M. E. et al. Differences between pediatric and adult T Cell responses to in vitro staphylococcal enterotoxin B stimulation. Front. Immunol. 9, 498 (2018).","journal-title":"Front. Immunol."},{"key":"2549_CR102","first-page":"681","volume":"9","author":"G Di Sante","year":"2022","unstructured":"Di Sante, G. et al. Immunopathology of SARS-CoV-2 infection: a focus on T regulatory and B cell responses in children compared with adults. Children (Basel) 9, 681 (2022).","journal-title":"Children (Basel)"},{"key":"2549_CR103","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22, 829\u2013838 (2021).","journal-title":"Nat. Immunol."},{"key":"2549_CR104","doi-asserted-by":"crossref","first-page":"741796","DOI":"10.3389\/fimmu.2021.741796","volume":"12","author":"MR Petrara","year":"2021","unstructured":"Petrara, M. R. et al. Asymptomatic and mild SARS-CoV-2 infections elicit lower immune activation and higher specific neutralizing antibodies in children than in adults. Front. Immunol. 12, 741796 (2021).","journal-title":"Front. Immunol."},{"key":"2549_CR105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2014.04.007","volume":"35","author":"DJ Dowling","year":"2014","unstructured":"Dowling, D. J. & Levy, O. Ontogeny of early life immunity. Trends Immunol. 35, 299\u2013310 (2014).","journal-title":"Trends Immunol."},{"key":"2549_CR106","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing, A. G. et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 26, 1623\u20131635 (2020).","journal-title":"Nat. Med."},{"key":"2549_CR107","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636\u20131643 (2020).","journal-title":"Nat. Med."},{"key":"2549_CR108","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1172\/JCI141113","volume":"130","author":"PY Lee","year":"2020","unstructured":"Lee, P. Y. et al. Distinct clinical and immunological features of SARS\u2013CoV-2\u2013induced multisystem inflammatory syndrome in children. J. Clin. Invest. 130, 5942\u20135950 (2020).","journal-title":"J. Clin. Invest."},{"key":"2549_CR109","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41590-021-01051-8","volume":"22","author":"S Ravichandran","year":"2021","unstructured":"Ravichandran, S. et al. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nat. Immunol. 22, 1452\u20131464 (2021).","journal-title":"Nat. Immunol."},{"key":"2549_CR110","doi-asserted-by":"crossref","first-page":"e20201707","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2021","unstructured":"Rodrigues, T. S. et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 218, e20201707 (2021).","journal-title":"J. Exp. Med."},{"key":"2549_CR111","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3390\/v13112239","volume":"13","author":"AE Kennedy","year":"2021","unstructured":"Kennedy, A. E. et al. Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections. Viruses 13, 2239 (2021).","journal-title":"Viruses"},{"key":"2549_CR112","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S2352-4642(22)00028-1","volume":"6","author":"AR Yousaf","year":"2022","unstructured":"Yousaf, A. R. et al. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Lancet Child Adolesc. Health 6, 303\u2013312 (2022).","journal-title":"Lancet Child Adolesc. Health"},{"key":"2549_CR113","doi-asserted-by":"crossref","first-page":"e2021055956","DOI":"10.1542\/peds.2021-055956","volume":"150","author":"C Karatzios","year":"2022","unstructured":"Karatzios, C. et al. Multisystem inflammatory syndrome following SARS-CoV-2 vaccination in two children. Pediatrics 150, e2021055956 (2022).","journal-title":"Pediatrics"},{"key":"2549_CR114","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/vaccines10071136","volume":"10","author":"V Santilli","year":"2022","unstructured":"Santilli, V. et al. Two pediatric cases of multisystem inflammatory syndrome with overlapping neurological involvement following SARS-CoV-2 vaccination and unknown SARS-CoV2 infection: the importance of pre-vaccination history. Vaccines 10, 1136 (2022).","journal-title":"Vaccines"},{"key":"2549_CR115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster, M. E. et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US From December 2020 to August 2021. JAMA 327, 331\u2013340 (2022).","journal-title":"JAMA"},{"key":"2549_CR116","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0140-6736(22)00791-7","volume":"399","author":"H-L Wong","year":"2022","unstructured":"Wong, H.-L. et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet Lond. Engl. 399, 2191\u20132199 (2022).","journal-title":"Lancet Lond. Engl."},{"key":"2549_CR117","doi-asserted-by":"publisher","unstructured":"Manno, E. C. et al. Higher troponin levels on admission are associated with persistent cardiac magnetic resonance lesions in children developing myocarditis after mRNA-based COVID-19 vaccination. Pediatr. Infect. Dis. J. 42, 166\u2013171. https:\/\/doi.org\/10.1097\/INF.0000000000003762 (2023).","DOI":"10.1097\/INF.0000000000003762"},{"key":"2549_CR118","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","volume":"165","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology 165, 386\u2013401 (2022).","journal-title":"Immunology"},{"key":"2549_CR119","doi-asserted-by":"crossref","first-page":"100393","DOI":"10.1016\/j.lanepe.2022.100393","volume":"17","author":"N Ouldali","year":"2022","unstructured":"Ouldali, N. et al. Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study. Lancet Reg. Health Eur. 17, 100393 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"2549_CR120","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1001\/jama.2022.8025","volume":"327","author":"N Levy","year":"2022","unstructured":"Levy, N. et al. Severity and incidence of multisystem inflammatory syndrome in children during 3 SARS-CoV-2 pandemic waves in Israel. JAMA 327, 2452\u20132454 (2022).","journal-title":"JAMA"},{"key":"2549_CR121","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41591-021-01578-1","volume":"28","author":"C Smith","year":"2022","unstructured":"Smith, C. et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat. Med. 28, 185\u2013192 (2022).","journal-title":"Nat. Med."},{"key":"2549_CR122","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm7131a3","volume":"71","author":"L Kompaniyets","year":"2022","unstructured":"Kompaniyets, L. et al. Post-COVID-19 symptoms and conditions among children and adolescents \u2013 United States, March 1, 2020-January 31, 2022. MMWR Morb. Mortal. Wkly. Rep. 71, 993\u2013999 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2549_CR123","doi-asserted-by":"crossref","first-page":"e2116420","DOI":"10.1001\/jamanetworkopen.2021.16420","volume":"4","author":"AB Payne","year":"2021","unstructured":"Payne, A. B. et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw. Open 4, e2116420 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2549_CR124","doi-asserted-by":"publisher","unstructured":"Dufort, E. M. et al. Multisystem inflammatory syndrome in children in New York State. N. Engl. J. Med. 383, 347\u2013358. https:\/\/doi.org\/10.1056\/NEJMoa2021756 (2020).","DOI":"10.1056\/NEJMoa2021756"},{"key":"2549_CR125","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1093\/cid\/ciab1007","volume":"75","author":"AD Miller","year":"2022","unstructured":"Miller, A. D. et al. Multisystem inflammatory syndrome in children-United States, February 2020-July 2021. Clin. Infect. Dis. 75, e1165\u2013e1175 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"2549_CR126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.003","volume":"226","author":"JY Abrams","year":"2020","unstructured":"Abrams, J. Y. et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J. Pediatr. 226, 45\u201354.e1 (2020).","journal-title":"J. Pediatr."},{"key":"2549_CR127","doi-asserted-by":"crossref","first-page":"e2020024554","DOI":"10.1542\/peds.2020-024554","volume":"147","author":"C Bautista-Rodriguez","year":"2021","unstructured":"Bautista-Rodriguez, C. et al. Multisystem inflammatory syndrome in children: an international survey. Pediatrics 147, e2020024554 (2021).","journal-title":"Pediatrics"},{"key":"2549_CR128","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1007\/s10067-021-05754-z","volume":"40","author":"G Alkan","year":"2021","unstructured":"Alkan, G., Sert, A., Oz, S. K. T., Emiroglu, M. & Y\u0131lmaz, R. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia. Clin. Rheumatol. 40, 4179\u20134189 (2021).","journal-title":"Clin. Rheumatol."},{"key":"2549_CR129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","volume":"27","author":"P Brodin","year":"2021","unstructured":"Brodin, P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med. 27, 28\u201333 (2021).","journal-title":"Nat. Med."},{"key":"2549_CR130","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.medj.2021.08.002","volume":"2","author":"C de Cevins","year":"2021","unstructured":"de Cevins, C. et al. A monocyte\/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med 2, 1072\u20131092.e7 (2021).","journal-title":"Med"},{"key":"2549_CR131","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee, P. Y. et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J. Allergy Clin. Immunol. 146, 1194\u20131200.e1 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2549_CR132","doi-asserted-by":"crossref","unstructured":"Kumar, D. et al. Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis. J. Allergy Clin. Immunol. 149, 1592\u20131606.e16 (2022).","DOI":"10.1016\/j.jaci.2022.02.028"},{"key":"2549_CR133","doi-asserted-by":"publisher","unstructured":"Benamar, M. et al. The Notch1\/CD22 signaling axis disrupts Treg cell function in SARS-CoV2-associated multisystem inflammatory syndrome in children. J. Clin. Invest. e163235. https:\/\/doi.org\/10.1172\/JCI163235 (2022).","DOI":"10.1172\/JCI163235"},{"key":"2549_CR134","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3201\/eid2704.210026","volume":"27","author":"YJ Choe","year":"2021","unstructured":"Choe, Y. J. et al. Surveillance of COVID-19\u2013associated multisystem inflammatory syndrome in children, South Korea. Emerg. Infect. Dis. 27, 1196\u20131200 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"2549_CR135","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jaci.2021.06.024","volume":"148","author":"J Chou","year":"2021","unstructured":"Chou, J. et al. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J. Allergy Clin. Immunol. 148, 732\u2013738.e1 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2549_CR136","unstructured":"Lee, D. et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science 379, eabo3627 (2023)."},{"key":"2549_CR137","doi-asserted-by":"crossref","unstructured":"Brodin, P. Exaggerated responses to a virus long gone. Science 379, 538\u2013539 (2023).","DOI":"10.1126\/science.adg2776"},{"key":"2549_CR138","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","volume":"117","author":"MH Cheng","year":"2020","unstructured":"Cheng, M. H. et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl Acad. Sci. USA. 117, 25254\u201325262 (2020).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"2549_CR139","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41591-020-1140-9","volume":"26","author":"OM Martinez","year":"2020","unstructured":"Martinez, O. M., Bridges, N. D., Goldmuntz, E. & Pascual, V. The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges. Nat. Med. 26, 1819\u20131824 (2020).","journal-title":"Nat. Med."},{"key":"2549_CR140","first-page":"e935005","volume":"27","author":"DV Parums","year":"2021","unstructured":"Parums, D. V. Editorial: multisystem inflammatory syndrome in adults (MIS-A) and the spectrum of COVID-19. Med. Sci. Monit. 27, e935005 (2021).","journal-title":"Med. Sci. Monit."},{"key":"2549_CR141","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1172\/JCI145301","volume":"130","author":"JE Weatherhead","year":"2020","unstructured":"Weatherhead, J. E., Clark, E., Vogel, T. P., Atmar, R. L. & Kulkarni, P. A. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum. J. Clin. Invest 130, 6194\u20136197 (2020).","journal-title":"J. Clin. Invest"},{"key":"2549_CR142","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.15585\/mmwr.mm6940e1","volume":"69","author":"SB Morris","year":"2020","unstructured":"Morris, S. B. et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection \u2014 United Kingdom and United States, March\u2013August 2020. MMWR Morb. Mortal. Wkly. Rep. 69, 1450\u20131456 (2020).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2549_CR143","doi-asserted-by":"crossref","first-page":"718744","DOI":"10.3389\/fimmu.2021.718744","volume":"12","author":"A Ronit","year":"2021","unstructured":"Ronit, A. et al. Host genetics and antiviral immune responses in adult patients with multisystem inflammatory syndrome. Front. Immunol. 12, 718744 (2021).","journal-title":"Front. Immunol."},{"key":"2549_CR144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.55729\/2000-9666.1087","volume":"12","author":"M Brown","year":"2022","unstructured":"Brown, M. et al. A case of adult multisystem inflammatory syndrome following COVID-19 vaccine. J. Community Hosp. Intern. Med. Perspect. 12, 7\u201313 (2022).","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"2549_CR145","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/vaccines9111353","volume":"9","author":"R Buchhorn","year":"2021","unstructured":"Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J. & Heidecke, H. Autoantibody release in children after corona virus mRNA vaccination: a risk factor of multisystem inflammatory syndrome? Vaccines 9, 1353 (2021).","journal-title":"Vaccines"},{"key":"2549_CR146","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3201\/eid2707.210594","volume":"27","author":"MB Salzman","year":"2021","unstructured":"Salzman, M. B., Huang, C.-W., O\u2019Brien, C. M. & Castillo, R. D. Multisystem inflammatory syndrome after SARS-CoV-2 infection and COVID-19 vaccination. Emerg. Infect. Dis. 27, 1944\u20131948 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"2549_CR147","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2021.23262","volume":"327","author":"M Levy","year":"2022","unstructured":"Levy, M. et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA 327, 281\u2013283 (2022).","journal-title":"JAMA"},{"key":"2549_CR148","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15585\/mmwr.mm7102e1","volume":"71","author":"LD Zambrano","year":"2022","unstructured":"Zambrano, L. D. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12\u201318 years \u2014 United States, July\u2013December 2021. MMWR Morb. Mortal. Wkly. Rep. 71, 52\u201358 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2549_CR149","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/apa.15870","volume":"110","author":"D Buonsenso","year":"2021","unstructured":"Buonsenso, D. et al. Preliminary evidence on long COVID in children. Acta Paediatr. 110, 2208\u20132211 (2021).","journal-title":"Acta Paediatr."},{"key":"2549_CR150","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1097\/INF.0000000000003328","volume":"40","author":"P Zimmermann","year":"2021","unstructured":"Zimmermann, P., Pittet, L. F. & Curtis, N. How common is long COVID in children and adolescents? Pediatr. Infect. Dis. J. 40, e482\u2013e487 (2021).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2549_CR151","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210\u2013216 (2022).","journal-title":"Nat. Immunol."},{"key":"2549_CR152","doi-asserted-by":"publisher","unstructured":"Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.08.09.22278592 (2022).","DOI":"10.1101\/2022.08.09.22278592"},{"key":"2549_CR153","doi-asserted-by":"crossref","first-page":"922422","DOI":"10.3389\/fcimb.2022.922422","volume":"12","author":"MAF Queiroz","year":"2022","unstructured":"Queiroz, M. A. F. et al. Cytokine profiles associated with acute COVID-19 and Long COVID-19 syndrome. Front. Cell. Infect. Microbiol. 12, 922422 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2549_CR154","doi-asserted-by":"crossref","first-page":"e154886","DOI":"10.1172\/JCI154886","volume":"131","author":"JS Knight","year":"2021","unstructured":"Knight, J. S. et al. The intersection of COVID-19 and autoimmunity. J. Clin. Invest. 131, e154886 (2021).","journal-title":"J. Clin. Invest."},{"key":"2549_CR155","doi-asserted-by":"publisher","unstructured":"See\u00dfle, J. et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin. Infect. Dis. 74, 1191\u20131198. https:\/\/doi.org\/10.1093\/cid\/ciab611 (2022).","DOI":"10.1093\/cid\/ciab611"},{"key":"2549_CR156","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895.e20 (2022).","journal-title":"Cell"},{"key":"2549_CR157","doi-asserted-by":"publisher","unstructured":"Brodin, P. et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 28, 879\u2013882. https:\/\/doi.org\/10.1038\/s41591-022-01766-7 (2022).","DOI":"10.1038\/s41591-022-01766-7"},{"key":"2549_CR158","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","volume":"18","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. 18, 2128\u20132130.e2 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2549_CR159","doi-asserted-by":"crossref","first-page":"596898","DOI":"10.3389\/fendo.2020.596898","volume":"11","author":"D Fignani","year":"2020","unstructured":"Fignani, D. et al. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) is expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature. Front. Endocrinol. 11, 596898 (2020).","journal-title":"Front. Endocrinol."},{"key":"2549_CR160","unstructured":"Increase in severe acute hepatitis cases of unknown aetiology in children. European Centre for Disease Prevention and Control; https:\/\/www.ecdc.europa.eu\/en\/increase-severe-acute-hepatitis-cases-unknown-aetiology-children."},{"key":"2549_CR161","unstructured":"Acute hepatitis: technical briefing. GOV.UK; https:\/\/www.gov.uk\/government\/publications\/acute-hepatitis-technical-briefing."},{"key":"2549_CR162","unstructured":"Israel examining 12 cases of kids\u2019 hepatitis after WHO warning \u2013 Israel News. https:\/\/www.haaretz.com\/israel-news\/israel-examining-12-cases-of-kids-hepatitis-after-who-warning-1.10752779."},{"key":"2549_CR163","doi-asserted-by":"crossref","first-page":"149633","DOI":"10.1172\/JCI149633","volume":"131","author":"LM Yonker","year":"2021","unstructured":"Yonker, L. M. et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Invest. 131, 149633 (2021).","journal-title":"J. Clin. Invest."},{"key":"2549_CR164","doi-asserted-by":"publisher","unstructured":"Brodin, P. & Arditi, M. Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens. Lancet Gastroenterol. Hepatol. 7, 594\u2013595. https:\/\/doi.org\/10.1016\/S2468-1253(22)00166-2 (2022).","DOI":"10.1016\/S2468-1253(22)00166-2"},{"key":"2549_CR165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.abf6648","volume":"372","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues. Science 372, 738\u2013741 (2021).","journal-title":"Science"},{"key":"2549_CR166","unstructured":"Children. COVID-19 Treatment Guidelines; https:\/\/www.covid19treatmentguidelines.nih.gov\/special-populations\/children\/."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02549-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02549-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T09:22:50Z","timestamp":1690536170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02549-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":166,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02549-7","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"29 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}